EUVIMEDEUVIMED entdecken
Crossref

Optimal timing of surgery after neoadjuvant chemoradiotherapy in rectal cancer: A retrospective analysis

Mojtaba Ahmadinejad, Arash Parvizi, Saman Sheikhi, Fatemeh Eghbal, Susan Navabian, Faranak Chaboki, Mohammad Hadi Bahri, Ramin Bozorgmehr, Javad Zebarjadi Bagherpour, Shirin Ziaie

European Journal of Surgical Oncology · 2025

DOI: 10.1016/j.ejso.2025.109702 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2025. Verfasst von Mojtaba Ahmadinejad und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, School of Medicine, Alborz University of Medical Science, Karaj, Iran. Electronic address: md.m.ahmadinejad@gmail.com. Hauptthemen laut MEDLINE: Rectal Neoplasms, Neoadjuvant Therapy, Chemoradiotherapy, Adjuvant, Proctectomy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Determining the optimal interval between neoadjuvant chemoradiotherapy (NCRT) and surgery in patients with locally advanced rectal cancer (LARC) remains crucial for improving treatment outcomes. Extending the interval may increase rates of pathological complete response (pCR), potentially enhancing survival and reducing recurrence. METHODS: This retrospective cohort study included 226 patients with LARC who underwent NCRT followed by surgery. ROC analysis was used to establish the optimal interval between NCRT and surgery for achieving pCR, and multivariate logistic regression assessed independent predictors of pCR. Spline regression further analyzed the relationship between surgery timing and the probability of pCR. RESULTS: ROC analysis identified 10.5 weeks as the optimal interval, showing increased pCR rates within this period. Multivariate analysis confirmed that surgery interval (OR = 2.603, P = 0.045) significantly predicted pCR. Both ROC and spline regression indicated that a 9-11-week interval maximizes pCR probability. Notably, the comparison of postoperative complications between groups with surgery intervals ≤10 weeks and >10 weeks showed no statistically significant differences (P = 0.518). CONCLUSION: An interval of 9-11 weeks between NCRT and surgery optimizes pCR rates without increasing postoperative risks. This timeframe may serve as a favorable window for surgical intervention to enhance outcomes in rectal cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rectal NeoplasmsNeoadjuvant TherapyChemoradiotherapy, AdjuvantProctectomyHumansMaleRetrospective StudiesFemaleMiddle AgedAgedTime FactorsAdultNeoplasm StagingROC CurveChemoradiotherapyPostoperative ComplicationsTreatment Outcome

Stichwörter der Autor:innen

Advanced rectal cancerComplete pathologic responseComplicationInterval timeNeoadjuvant therapySurgery

Autor:innen und Institutionen

  • Department of Surgery, School of Medicine, Alborz University of Medical Science, Karaj, Iran. Electronic address: md.m.ahmadinejad@gmail.com.
  • Radiation Oncology, Independent Practice, Karaj, Iran. Electronic address: parviziarash@gmail.com.
  • Department of Surgery, School of Medicine, Alborz University of Medical Science, Karaj, Iran. Electronic address: S.sheikhi@abzums.ac.ir.
  • Student Research Committee, Alborz University of Medical Sciences, Karaj, Iran. Electronic address: fatemeheghbal7@gmail.com.
  • General Practitioner, Independent Practice, Karaj, Iran. Electronic address: Susan.navabian@yahoo.com.
  • Student Research Committee, Alborz University of Medical Sciences, Karaj, Iran. Electronic address: Faranak.chaboki97@gmail.com.

Zitieren

APA

Ahmadinejad, M., Parvizi, A., Sheikhi, S., Eghbal, F., Navabian, S., Chaboki, F., Bahri, M. H., Bozorgmehr, R., Bagherpour, J. Z., & Ziaie, S. (2025). Optimal timing of surgery after neoadjuvant chemoradiotherapy in rectal cancer: A retrospective analysis. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2025.109702

Vancouver

Ahmadinejad M, Parvizi A, Sheikhi S, Eghbal F, Navabian S, Chaboki F, et al. Optimal timing of surgery after neoadjuvant chemoradiotherapy in rectal cancer: A retrospective analysis. European Journal of Surgical Oncology. 2025. doi:10.1016/j.ejso.2025.109702

BibTeX
@article{Ahmadinejad2025,
  author = {Ahmadinejad, Mojtaba and Parvizi, Arash and Sheikhi, Saman and Eghbal, Fatemeh and Navabian, Susan and Chaboki, Faranak and Bahri, Mohammad Hadi and Bozorgmehr, Ramin and Bagherpour, Javad Zebarjadi and Ziaie, Shirin},
  title = {Optimal timing of surgery after neoadjuvant chemoradiotherapy in rectal cancer: A retrospective analysis},
  journal = {European Journal of Surgical Oncology},
  year = {2025},
  doi = {10.1016/j.ejso.2025.109702}
}
Kostenlos starten →